
Tan V. Mai
Examiner (ID: 12217, Phone: (571)272-3726 , Office: P/2182 )
| Most Active Art Unit | 2193 |
| Art Unit(s) | 2301, 2306, 2787, 2183, 2302, 2182, 2786, 2193, 2121, 2124 |
| Total Applications | 3863 |
| Issued Applications | 3434 |
| Pending Applications | 94 |
| Abandoned Applications | 349 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17579151
[patent_doc_number] => 20220136006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/428401
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428401
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428401 | RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME | Feb 3, 2020 | Abandoned |
Array
(
[id] => 17358057
[patent_doc_number] => 20220018853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => USE OF GILZ AS A BIOMARKER IN SEPSIS
[patent_app_type] => utility
[patent_app_number] => 17/311474
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311474 | USE OF GILZ AS A BIOMARKER IN SEPSIS | Dec 5, 2019 | Pending |
Array
(
[id] => 15800799
[patent_doc_number] => 20200123542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => RNA COMPOSITIONS FOR GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 16/703766
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703766 | RNA COMPOSITIONS FOR GENOME EDITING | Dec 3, 2019 | Pending |
Array
(
[id] => 19763361
[patent_doc_number] => 12221640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Method for promoting n-acetylglucosamine synthesis by using GlcN6P responsive element
[patent_app_type] => utility
[patent_app_number] => 17/279271
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4311
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279271 | Method for promoting n-acetylglucosamine synthesis by using GlcN6P responsive element | Nov 25, 2019 | Issued |
Array
(
[id] => 17292198
[patent_doc_number] => 20210388037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => LEADER SEQUENCE FOR YEAST
[patent_app_type] => utility
[patent_app_number] => 17/293240
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293240 | LEADER SEQUENCE FOR YEAST | Nov 17, 2019 | Pending |
Array
(
[id] => 18916730
[patent_doc_number] => 11879000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10)
[patent_app_type] => utility
[patent_app_number] => 16/685565
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 36
[patent_no_of_words] => 19612
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685565 | Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10) | Nov 14, 2019 | Issued |
Array
(
[id] => 17336423
[patent_doc_number] => 20220002754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => USE OF NW_006883358.1 IN CHO CELL GENOME FOR STABLE EXPRESSION OF PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/289015
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289015 | USE OF NW_006883358.1 IN CHO CELL GENOME FOR STABLE EXPRESSION OF PROTEIN | Oct 21, 2019 | Pending |
Array
(
[id] => 17243766
[patent_doc_number] => 20210363509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
[patent_app_type] => utility
[patent_app_number] => 17/287184
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287184 | Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein | Oct 21, 2019 | Pending |
Array
(
[id] => 15619405
[patent_doc_number] => 20200080107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => UNIVERSAL DONOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/563573
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16563573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/563573 | Universal donor cells | Sep 5, 2019 | Issued |
Array
(
[id] => 17154964
[patent_doc_number] => 20210316015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/273805
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273805 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASE | Sep 4, 2019 | Pending |
Array
(
[id] => 15553599
[patent_doc_number] => 20200061211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS
[patent_app_type] => utility
[patent_app_number] => 16/547019
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547019 | METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS | Aug 20, 2019 | Pending |
Array
(
[id] => 15993527
[patent_doc_number] => 20200172634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => Expression Constructs and Methods for Expressing Polypeptides in Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 16/512482
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512482 | Expression Constructs and Methods for Expressing Polypeptides in Eukaryotic Cells | Jul 15, 2019 | Abandoned |
Array
(
[id] => 18794121
[patent_doc_number] => 11827877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Compositions and methods for genomic editing by insertion of donor polynucleotides
[patent_app_type] => utility
[patent_app_number] => 16/457528
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 75802
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457528 | Compositions and methods for genomic editing by insertion of donor polynucleotides | Jun 27, 2019 | Issued |
Array
(
[id] => 15024063
[patent_doc_number] => 20190323036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => METHOD TO BUILD FUNGAL PRODUCTION STRAINS USING AUTOMATED STEPS FOR GENETIC MANIPULATION AND STRAIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/453260
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453260 | METHOD TO BUILD FUNGAL PRODUCTION STRAINS USING AUTOMATED STEPS FOR GENETIC MANIPULATION AND STRAIN PURIFICATION | Jun 25, 2019 | Abandoned |
Array
(
[id] => 17022582
[patent_doc_number] => 20210246453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => MATERIALS AND METHODS FOR MODULATING INTRAOCULAR AND INTRACRANIAL PRESSURE
[patent_app_type] => utility
[patent_app_number] => 16/973894
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -105
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973894 | MATERIALS AND METHODS FOR MODULATING INTRAOCULAR AND INTRACRANIAL PRESSURE | Jun 10, 2019 | Abandoned |
Array
(
[id] => 16778371
[patent_doc_number] => 20210115449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/047367
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047367 | THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES | Apr 17, 2019 | Pending |
Array
(
[id] => 17541216
[patent_doc_number] => 11306329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/279688
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 27082
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279688 | Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof | Feb 18, 2019 | Issued |
Array
(
[id] => 15087091
[patent_doc_number] => 20190338356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => CONSTRUCTS AND METHODS FOR SIGNAL AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/270198
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270198 | CONSTRUCTS AND METHODS FOR SIGNAL AMPLIFICATION | Feb 6, 2019 | Abandoned |
Array
(
[id] => 14625211
[patent_doc_number] => 20190225973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => NOVEL SACCHAROMYCES CEREVISIAE EXPRESSION SYSTEM AND CONSTRUCTION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/252934
[patent_app_country] => US
[patent_app_date] => 2019-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252934 | NOVEL SACCHAROMYCES CEREVISIAE EXPRESSION SYSTEM AND CONSTRUCTION METHOD THEREOF | Jan 20, 2019 | Abandoned |
Array
(
[id] => 17220733
[patent_doc_number] => 11173216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Gene editing-based method of attenuating the beta-amyloid pathway
[patent_app_type] => utility
[patent_app_number] => 16/251970
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 18
[patent_no_of_words] => 13294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16251970
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/251970 | Gene editing-based method of attenuating the beta-amyloid pathway | Jan 17, 2019 | Issued |